These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35262187)

  • 1. Yield of baseline imaging for distant metastases in high-risk primary melanoma.
    Yan MK; Adler NR; Pan Y; Chamberlain A; Kelly J; Yap K; Voskoboynik M; Haydon A; Shackleton M; Mar VJ
    J Surg Oncol; 2022 Jun; 125(8):1312-1317. PubMed ID: 35262187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of surveillance imaging for resected high-risk melanoma.
    Yan MK; Adler NR; Wolfe R; Pan Y; Chamberlain A; Kelly J; Yap K; Voskoboynik M; Haydon A; Shackleton M; Mar VJ
    Asia Pac J Clin Oncol; 2023 Aug; 19(4):566-573. PubMed ID: 36540019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline staging in cutaneous malignant melanoma.
    Hafner J; Schmid MH; Kempf W; Burg G; Künzi W; Meuli-Simmen C; Neff P; Meyer V; Mihic D; Garzoli E; Jungius KP; Seifert B; Dummer R; Steinert H
    Br J Dermatol; 2004 Apr; 150(4):677-86. PubMed ID: 15099363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage-Specific Risk of Recurrence and Death From Melanoma in Denmark, 2008-2021: A National Observational Cohort Study of 25 720 Patients With Stage IA to IV Melanoma.
    Helvind NM; Brinch-Møller Weitemeyer M; Chakera AH; Hendel HW; Ellebæk E; Svane IM; Kjærskov MW; Bojesen S; Skyum H; Petersen SK; Bastholt L; Johansen C; Bidstrup PE; Hölmich LR
    JAMA Dermatol; 2023 Nov; 159(11):1213-1222. PubMed ID: 37650576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging of cutaneous melanoma.
    Mohr P; Eggermont AM; Hauschild A; Buzaid A
    Ann Oncol; 2009 Aug; 20 Suppl 6(Suppl 6):vi14-21. PubMed ID: 19617293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients.
    Tan SY; Najita J; Li X; Strazzulla LC; Dunbar H; Lee MY; Seery VJ; Buchbinder EI; Tawa NE; McDermott DF; Lee SJ; Atkins MB; Kim CC
    Melanoma Res; 2019 Feb; 29(1):70-76. PubMed ID: 30169431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma.
    Kanaki T; Stang A; Gutzmer R; Zimmer L; Chorti E; Sucker A; Ugurel S; Hadaschik E; Gräger NS; Satzger I; Schadendorf D; Livingstone E
    Eur J Cancer; 2019 Sep; 119():18-29. PubMed ID: 31401470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: a retrospective analysis of 61 patients with malignant melanoma in American Joint Committee on Cancer stages I and II.
    Klode J; Dissemond J; Grabbe S; Hillen U; Poeppel T; Boeing C
    Dermatol Surg; 2010 Apr; 36(4):439-45. PubMed ID: 20187901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?
    Madu MF; Franke V; Van de Wiel BA; Klop WMC; Jóźwiak K; van Houdt WJ; Wouters MWJM; van Akkooi ACJ
    Melanoma Res; 2020 Apr; 30(2):185-192. PubMed ID: 31651715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection.
    Belhocine T; Pierard G; De Labrassinne M; Lahaye T; Rigo P
    Oncologist; 2002; 7(4):271-8. PubMed ID: 12185291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial staging of malignant melanoma by positron emission tomography and sentinel node biopsy.
    Libberecht K; Husada G; Peeters T; Michiels P; Gys T; Molderez C
    Acta Chir Belg; 2005; 105(6):621-5. PubMed ID: 16438072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.
    Singh B; Ezziddin S; Palmedo H; Reinhardt M; Strunk H; Tüting T; Biersack HJ; Ahmadzadehfar H
    Melanoma Res; 2008 Oct; 18(5):346-52. PubMed ID: 18781133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden.
    Satzger I; Leiter U; Gräger N; Keim U; Garbe C; Gutzmer R
    Eur J Cancer; 2019 Dec; 123():83-91. PubMed ID: 31677550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
    Wagner T; Meyer N; Zerdoud S; Julian A; Chevreau C; Payoux P; Courbon F
    Br J Dermatol; 2011 Jun; 164(6):1235-40. PubMed ID: 21332457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
    Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma.
    Eggermont AMM; Blank CU; Mandala M; Long GV; Atkinson VG; Dalle S; Haydon A; Lichinitser M; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJ; Grob JJ; Gutzmer R; Jamal R; Lorigan PC; Lupinacci R; Krepler C; Ibrahim N; Kicinski M; Marreaud S; van Akkooi AC; Suciu S; Robert C
    Eur J Cancer; 2019 Jul; 116():148-157. PubMed ID: 31200321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk and tropism of central nervous system (CNS) metastases in patients with stage II and III cutaneous melanoma.
    Johannet P; Simons M; Qian Y; Azmy N; Mehnert JM; Weber JS; Zhong J; Osman I
    Cancer; 2022 Oct; 128(20):3620-3629. PubMed ID: 36006879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of adjuvant settings for Stage III melanoma patients in France prior to checkpoint inhibitors: epidemiological data from the RIC-Mel database.
    Dalle S; Varey E; Nguyen JM; Dupuy A; Montaudie H; Lesage C; Mortier L; Leccia MT; Skowron F; Celerier P; Meyer N; Dutriaux C; Dalac-Rat S; Khammari A; Lebbe C; Dréno B
    Eur J Dermatol; 2020 Aug; 30(4):389-396. PubMed ID: 32815816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of lymph node ultrasound and whole body
    Stahlie EHA; van der Hiel B; Bruining A; van de Wiel B; Schrage YM; Wouters MWJM; van Houdt WJ; van Akkooi ACJ
    Eur J Surg Oncol; 2021 May; 47(5):1157-1162. PubMed ID: 33353826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III Melanoma.
    Dieng M; Lord SJ; Turner RM; Nieweg OE; Menzies AM; Saw RPM; Einstein AJ; Emmett L; Thompson JF; Lo SN; Morton RL
    Ann Surg Oncol; 2022 May; 29(5):2871-2881. PubMed ID: 35142966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.